Source: Biochemical Pharmacology. Unidades: FCF, ICB
Subjects: LEUCEMIA, ESCHERICHIA COLI, PARASITOLOGIA, LISOSSOMOS, IMUNOGENÉTICA, BIOFARMÁCIA, LEUCEMIA, RESISTÊNCIA MICROBIANA ÀS DROGAS, REAÇÃO EM CADEIA POR POLIMERASE, ATIVAÇÃO ENZIMÁTICA, CITOTOXICIDADE IMUNOLÓGICA
ABNT
RODRIGUES, Mariane Augusta Domingues; BREYER, Carlos Alexandre; OLIVEIRA, Marcos A. de; et al. Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase. Biochemical Pharmacology, Oxford, v. 182, p. 1-14 art. 114230, 2020. Disponível em: < http://dx.doi.org/10.1016/j.bcp.2020.114230 > DOI: 10.1016/j.bcp.2020.114230.APA
Rodrigues, M. A. D., Breyer, C. A., Oliveira, M. A. de, Santiago, V. F., Palmisano, G., Barbosa, C. M. V., et al. (2020). Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase. Biochemical Pharmacology, 182, 1-14 art. 114230. doi:10.1016/j.bcp.2020.114230NLM
Rodrigues MAD, Breyer CA, Oliveira MA de, Santiago VF, Palmisano G, Barbosa CMV, Hebeda CB, Farsky SHP, Monteiro G, Pimenta MV, Costa IM, Zenatti PP, Migita NA, Yunes JA, Rangel-Yagui C de O, Sá MM de, Pessoa Junior A, Silva TA da C e, Toyama MH. Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase [Internet]. Biochemical Pharmacology. 2020 ; 182 1-14 art. 114230.Available from: http://dx.doi.org/10.1016/j.bcp.2020.114230Vancouver
Rodrigues MAD, Breyer CA, Oliveira MA de, Santiago VF, Palmisano G, Barbosa CMV, Hebeda CB, Farsky SHP, Monteiro G, Pimenta MV, Costa IM, Zenatti PP, Migita NA, Yunes JA, Rangel-Yagui C de O, Sá MM de, Pessoa Junior A, Silva TA da C e, Toyama MH. Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase [Internet]. Biochemical Pharmacology. 2020 ; 182 1-14 art. 114230.Available from: http://dx.doi.org/10.1016/j.bcp.2020.114230